new Fosamax (alendronate) tablets for ONCE-A-WEEK dosing
November 2000
Merck will soon market new Fosamax (alendronate) tablets for ONCE-A-WEEK dosing.
The new tabs come in two strengths...35 and 70 mg.
The 35 mg tab is for patients on 5 mg/d to PREVENT osteoporosis.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote